Resultats de la cerca - Saša Masleša‐Galić
- Mostrar 1 - 5 resultats de 5
-
1
Recombinant bacillus Calmette–Guérin (BCG) vaccines expressing the<i>Mycobacterium tuberculosis</i>30-kDa major secretory protein induce greater protective immunity against tubercu... per Marcus A. Horwitz, Günter Harth, Barbara Jane Dillon, Saša Masleša-Galić
Publicat 2000Artigo -
2
All four <i>Mycobacterium tuberculosis gln</i>A genes encode glutamine synthetase activities but only GlnA1 is abundantly expressed and essential for bacterial homeostasis per Günter Harth, Saša Masleša‐Galić, Michael V. Tullius, Marcus A. Horwitz
Publicat 2005Artigo -
3
A Replication-Limited Recombinant <i>Mycobacterium bovis</i> BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacio... per Michael V. Tullius, Günter Harth, Saša Masleša-Galić, Barbara Jane Dillon, Marcus A. Horwitz
Publicat 2008Artigo -
4
Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters per Qingmei Jia, Helle Bielefeldt‐Ohmann, Rachel M. Maison, Saša Masleša-Galić, Sarah K. Cooper, Richard A. Bowen, Marcus A. Horwitz
Publicat 2021Artigo -
5
Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time per Bai‐Yu Lee, Daniel L. Clemens, Aleidy Silva, Barbara Jane Dillon, Saša Masleša-Galić, Susana Nava, Xianting Ding, Chih‐Ming Ho, Marcus A. Horwitz
Publicat 2017Artigo
Eines de cerca:
Matèries relacionades
Biology
Medicine
Pathology
Biochemistry
Gene
Microbiology
Mycobacterium tuberculosis
Tuberculosis
Immunology
Virology
Attenuated vaccine
BCG vaccine
Molecular biology
Mycobacterium bovis
Recombinant DNA
Tuberculosis vaccines
Vaccination
Virulence
Amino acid
Bacilli
Bacteria
Bedaquiline
Biotechnology
Coronavirus disease 2019 (COVID-19)
Disease
Drug
Drug resistance
ESAT-6
Enzyme
Genetics